Evaluation of Materials for the Distribution of Pressure in the Treatment of Neuroischemic Ulcers
1 other identifier
interventional
46
1 country
1
Brief Summary
The hypothesis of this study is based on the premise that pressure-distributing materials with superior biomechanical and tissue response properties will be capable of improving the healing rate of neuropathic ulcers. The overarching objective of the present project is to assess the influence of the nature and method of application of the materials under study on tissue response, the reduction of pressure on the sole of the foot, and the healing of neuropathic ulcers in patients with diabetes mellitus.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 9, 2021
CompletedFirst Submitted
Initial submission to the registry
May 13, 2026
CompletedFirst Posted
Study publicly available on registry
June 2, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 8, 2027
June 2, 2026
May 1, 2026
5.8 years
May 13, 2026
May 26, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Near-infrared perfusion index (NIR perfusion)
Hyperspectral imaging was performed using the TIVITA® 2.0 camera (Diaspective Vision GmbH, Germany). This non-contact, non-invasive device captures images across multiple wavelengths within the visible and near-infrared spectrum (500-1000 nm), enabling assessment of microcirculatory parameters up to a tissue depth of approximately 8 mm. The device provides an image resolution of 640 × 480 pixels, with an acquisition time of 6.4 seconds. Images were analyzed using TIVITA® Suite software by selecting a circular region of interest adjusted to the metatarsal head and offloading area under study.
Baseline and 4 days
Secondary Outcomes (7)
Thermography
Baseline and 4 days
Peak pressure (Pmax)
Baseline and 4 days
Tissue oxygen saturation (StO₂)
Baseline and 4 days
Tissue hemoglobin index (THI)
Baseline and 4 days
Tissue wáter index (TWI)
Baseline and 4 days
- +2 more secondary outcomes
Study Arms (1)
felt padding
EXPERIMENTALThe 5 mm and 10 mm felt pads are applied for 4 days.
Interventions
The 5 mm felt pad is applied for 4 days and then removed. After allowing the skin at least 48 hours to recover, the 10 mm felt pad is applied, also for 4 days.
Eligibility Criteria
You may qualify if:
- Aged between 55 and 75.
- Diagnosis of diabetes mellitus.
- Patients with an ankle-brachial index of \>0.8 and \<1.2.
- Signature of the informed consent form
You may not qualify if:
- Leg or foot injuries or ulcers that cause pain and prevent normal movement in both lower limbs.
- Foot trauma within the last month.
- Inability to adhere to the full schedule of measurements required by the study.
- Participants who do not sign the informed consent form.
- Known contact dermatitis to any of the study materials
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Valencialead
- Instituto de Investigacion Sanitaria La Fecollaborator
Study Sites (1)
Hospital Universitario y Politécnico La Fe
Valencia, Valencia, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Medicine
Study Record Dates
First Submitted
May 13, 2026
First Posted
June 2, 2026
Study Start
March 9, 2021
Primary Completion (Estimated)
January 1, 2027
Study Completion (Estimated)
March 8, 2027
Last Updated
June 2, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share